The global auto-injectors market is estimated to be valued at US$ 4,497.7 million in 2022 and is expected to exhibit a CAGR of 18.0% during the forecast period (2022-2030).
Figure 1. Global Auto-injectors Market Share (%), by Product Type, 2022
Increasing inorganic strategies such as agreement is expected to boost the growth of global auto-injectors market. For instance, in May 2022, Stevanato Group, a manufacturer and distributor of drug containment, announced that they had signed an agreement with Owen Mumford Ltd., a manufacturer of medical device, for its Aidaptus auto-injector. This agreement will bring value to customers, matching world-class device expertise with premium manufacturing capabilities. Aidaptus auto-injector is a two-step, single use auto-injector with a versatile design that accommodates both 1 mL and 2.25 mL prefilled glass syringes in the same base device.
Figure 2. Global Auto-injectors Market Value (US$ Million), by Region, 2022
Report Coverage | |||
---|---|---|---|
Forecast Period 2022 to 2030 CAGR: | 18.0% | 2030 Value Projection: | US$ 16,953.2 Mn |
Geographies covered: | |||
Segments covered: | |||
Companies covered: | |||
Growth Drivers: |